New Zealand has tentatively cleared the COVID-19 vaccine that Pfizer (PFE) developed in partnership with BioNTech (BNTX) for 12-15-year olds, according to a Reuters report. “After careful consideration of the most up-to-date scientific and medical data available, Medsafe has announced provisional approval for our young people to be given the Pfizer vaccine,” Reuters quoted PM Jacinda Ardern as saying. Medsafe is New Zealand’s drugs regulator. The country has more than 250,000 children aged 12 - 15 years who now stand to benefit from the Pfizer vaccine. The vaccine rollout to this group will begin after Cabinet's approval, expected by the end of June.
https://www.tipranks.com/news/pfizer-vaccine-approved-for-12-15-year-olds-in-new-zealand-report
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more BioNTech Charts.
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more BioNTech Charts.